Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1

Interventions

Specimen Handling 483pembrolizumab 456Magnetic Resonance Spectroscopy 420Carboplatin 327Cyclophosphamide 315Biopsy 274Cisplatin 270Radiotherapy 244Paclitaxel 229Gemcitabine 225Bevacizumab 214Nivolumab 189fludarabine 184venetoclax 174Drug Therapy 171Dexamethasone 158Blood Specimen Collection 158Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 145Docetaxel 144Radiosurgery 137Standard of Care 136Rituximab 125Pemetrexed 117durvalumab 114atezolizumab 110Leucovorin 110Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Random Allocation × 1 year × Clear all
NCT06860269 2026-02-10

GRAALL-2024

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Recruiting
1,200 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06348719 2025-09-15

ROBOT-ECO-GYN

Rennes University Hospital

Phase NA Recruiting
1,680 enrolled
Gynecologic

Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡